Clinical trial

JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs.

NCT07154368

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-09-23

PhasePHASE3

Study timeline

Study start (estimated)2025-09-23Date precision: day

Registry last updated2025-09-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

Pemetrexed injectionDRUG · verified · RxNorm: pemetrexed Injection

Cross-over to JYP0322DRUG

JYP0322 tabletsDRUG

Sponsors & collaborators

Guangzhou JOYO Pharma Co., Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07154368 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.